As a consequence, the baseline KL-6 levels or any of the trends for the short-term KL-6 level changes were not associated with a progression of ILD as defined by the OMERACT criteria or PF-ILD (Table 4). This evidence concerns the gene MUC1 and interstitial lung disease.